Nevertheless, our results showed that HLA-C*08:01 occurred at a significantly higher frequency in the NSCLC group compared with the healthy control group and showed a significant difference between the two groups after FDR correction (OR=2.395; 95% CI: 1.359-4.221). The gene discussed is HLA-C; the disease is non-small cell lung carcinoma.